[Asia Economy Reporter Eunmo Koo] Il Sung Pharmaceutical announced on the 23rd that its operating loss turned to a deficit of 1.3 billion KRW last year compared to the previous year. During the same period, sales decreased by 21.48% to 48.4 billion KRW, while net profit increased by 83.53% to 5.4 billion KRW. The company explained, "Sales declined due to the termination of the license product contract, and net profit increased due to the rise in financial income."



This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing